首页 | 本学科首页   官方微博 | 高级检索  
文章检索
  按 检索   检索词:      
出版年份:   被引次数:   他引次数: 提示:输入*表示无穷大
  收费全文   1449145篇
  免费   112170篇
  国内免费   2610篇
耳鼻咽喉   20284篇
儿科学   48908篇
妇产科学   38095篇
基础医学   206940篇
口腔科学   38143篇
临床医学   127381篇
内科学   293718篇
皮肤病学   30675篇
神经病学   117384篇
特种医学   58174篇
外国民族医学   666篇
外科学   221131篇
综合类   28147篇
现状与发展   2篇
一般理论   634篇
预防医学   111928篇
眼科学   30956篇
药学   105155篇
  2篇
中国医学   2749篇
肿瘤学   82853篇
  2021年   12360篇
  2019年   13055篇
  2018年   17945篇
  2017年   13553篇
  2016年   14840篇
  2015年   16851篇
  2014年   23343篇
  2013年   34169篇
  2012年   48125篇
  2011年   50412篇
  2010年   29547篇
  2009年   28102篇
  2008年   47040篇
  2007年   49617篇
  2006年   49535篇
  2005年   48140篇
  2004年   46111篇
  2003年   44364篇
  2002年   42829篇
  2001年   67210篇
  2000年   69506篇
  1999年   59353篇
  1998年   17009篇
  1997年   15308篇
  1996年   15636篇
  1995年   14727篇
  1994年   13888篇
  1993年   12837篇
  1992年   46508篇
  1991年   45195篇
  1990年   43854篇
  1989年   41674篇
  1988年   38379篇
  1987年   37548篇
  1986年   34902篇
  1985年   33561篇
  1984年   25197篇
  1983年   21186篇
  1982年   12397篇
  1981年   11301篇
  1979年   22072篇
  1978年   15354篇
  1977年   12997篇
  1976年   12053篇
  1975年   12993篇
  1974年   15077篇
  1973年   14522篇
  1972年   13308篇
  1971年   12076篇
  1970年   11332篇
排序方式: 共有10000条查询结果,搜索用时 515 毫秒
1.
Molnár  B.  Aroca  S.  Dobos  A.  Orbán  K.  Szabó  J.  Windisch  P.  Stähli  A.  Sculean  A. 《Clinical oral investigations》2022,26(12):7135-7142
Clinical Oral Investigations - To evaluate t he long-term outcomes following treatment of RT 1 multiple adjacent gingival recessions (MAGR) using the modified coronally advanced tunnel (MCAT) with...  相似文献   
2.
3.
Intratumor heterogeneity is a main cause of the dismal prognosis of glioblastoma (GBM). Yet, there remains a lack of a uniform assessment of the degree of heterogeneity. With a multiscale approach, we addressed the hypothesis that intratumor heterogeneity exists on different levels comprising traditional regional analyses, but also innovative methods including computer-assisted analysis of tumor morphology combined with epigenomic data. With this aim, 157 biopsies of 37 patients with therapy-naive IDH-wildtype GBM were analyzed regarding the intratumor variance of protein expression of glial marker GFAP, microglia marker Iba1 and proliferation marker Mib1. Hematoxylin and eosin stained slides were evaluated for tumor vascularization. For the estimation of pixel intensity and nuclear profiling, automated analysis was used. Additionally, DNA methylation profiling was conducted separately for the single biopsies. Scoring systems were established to integrate several parameters into one score for the four examined modalities of heterogeneity (regional, cellular, pixel-level and epigenomic). As a result, we could show that heterogeneity was detected in all four modalities. Furthermore, for the regional, cellular and epigenomic level, we confirmed the results of earlier studies stating that a higher degree of heterogeneity is associated with poorer overall survival. To integrate all modalities into one score, we designed a predictor of longer survival, which showed a highly significant separation regarding the OS. In conclusion, multiscale intratumor heterogeneity exists in glioblastoma and its degree has an impact on overall survival. In future studies, the implementation of a broadly feasible heterogeneity index should be considered.  相似文献   
4.
5.
6.
7.
8.
9.
10.
Patient navigation is a strategy for overcoming barriers to reduce disparities and to improve access and outcomes. The aim of this umbrella review was to identify, critically appraise, synthesize, and present the best available evidence to inform policy and planning regarding patient navigation across the cancer continuum. Systematic reviews examining navigation in cancer care were identified in the Cochrane Central Register of Controlled Trials (CENTRAL), PubMed, Embase, Cumulative Index of Nursing and Allied Health (CINAHL), Epistemonikos, and Prospective Register of Systematic Reviews (PROSPERO) databases and in the gray literature from January 1, 2012, to April 19, 2022. Data were screened, extracted, and appraised independently by two authors. The JBI Critical Appraisal Checklist for Systematic Review and Research Syntheses was used for quality appraisal. Emerging literature up to May 25, 2022, was also explored to capture primary research published beyond the coverage of included systematic reviews. Of the 2062 unique records identified, 61 systematic reviews were included. Fifty-four reviews were quantitative or mixed-methods reviews, reporting on the effectiveness of cancer patient navigation, including 12 reviews reporting costs or cost-effectiveness outcomes. Seven qualitative reviews explored navigation needs, barriers, and experiences. In addition, 53 primary studies published since 2021 were included. Patient navigation is effective in improving participation in cancer screening and reducing the time from screening to diagnosis and from diagnosis to treatment initiation. Emerging evidence suggests that patient navigation improves quality of life and patient satisfaction with care in the survivorship phase and reduces hospital readmission in the active treatment and survivorship care phases. Palliative care data were extremely limited. Economic evaluations from the United States suggest the potential cost-effectiveness of navigation in screening programs.  相似文献   
设为首页 | 免责声明 | 关于勤云 | 加入收藏

Copyright©北京勤云科技发展有限公司  京ICP备09084417号